192 related articles for article (PubMed ID: 18196519)
1. Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse.
Huang CY; Bredemeyer AL; Walker LM; Bassing CH; Sleckman BP
Eur J Immunol; 2008 Feb; 38(2):342-9. PubMed ID: 18196519
[TBL] [Abstract][Full Text] [Related]
2. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
Roland J; Morello D
Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
[TBL] [Abstract][Full Text] [Related]
3. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
4. B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation.
Gregory MA; Xiao Q; Cornwall GA; Lutterbach B; Hann SR
Oncogene; 2000 Oct; 19(42):4886-95. PubMed ID: 11039906
[TBL] [Abstract][Full Text] [Related]
5. By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP+ fluorescent mouse.
Arata N; Ando T; Unger P; Davies TF
Clin Immunol; 2006 Oct; 121(1):108-17. PubMed ID: 16916620
[TBL] [Abstract][Full Text] [Related]
6. Expression of a rlf/L-myc minigene inhibits differentiation of embryonic stem cells and embroid body formation.
MacLean-Hunter S; Mäkelä TP; Grzeschiczek A; Alitalo K; Möröy T
Oncogene; 1994 Dec; 9(12):3509-17. PubMed ID: 7970711
[TBL] [Abstract][Full Text] [Related]
7. Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death.
Arnaud-Dabernat S; Masse K; Smani M; Peuchant E; Landry M; Bourbon PM; Le Floch R; Daniel JY; Larou M
Exp Cell Res; 2004 Dec; 301(2):293-304. PubMed ID: 15530864
[TBL] [Abstract][Full Text] [Related]
8. Novel reporter cell line to analyze cytokine-mediated expression regulation of c-myc gene.
Fujii H
J Biosci Bioeng; 2009 Nov; 108(5):438-40. PubMed ID: 19804871
[TBL] [Abstract][Full Text] [Related]
9. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development.
Mycko MP; Ferrero I; Wilson A; Jiang W; Bianchi T; Trumpp A; MacDonald HR
J Immunol; 2009 Apr; 182(8):4641-8. PubMed ID: 19342639
[TBL] [Abstract][Full Text] [Related]
10. Defining the specific physiological requirements for c-Myc in T cell development.
Douglas NC; Jacobs H; Bothwell AL; Hayday AC
Nat Immunol; 2001 Apr; 2(4):307-15. PubMed ID: 11276201
[TBL] [Abstract][Full Text] [Related]
11. Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster.
Benassayag C; Montero L; Colombié N; Gallant P; Cribbs D; Morello D
Mol Cell Biol; 2005 Nov; 25(22):9897-909. PubMed ID: 16260605
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
13. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
[TBL] [Abstract][Full Text] [Related]
14. Heart-specific inhibition of protooncogene c-myc attenuates cold-induced cardiac hypertrophy.
Bello Roufai M; Li H; Sun Z
Gene Ther; 2007 Oct; 14(19):1406-16. PubMed ID: 17637797
[TBL] [Abstract][Full Text] [Related]
15. Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets.
Pascal SM; Guiot Y; Pelengaris S; Khan M; Jonas JC
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E92-102. PubMed ID: 18413670
[TBL] [Abstract][Full Text] [Related]
16. Healthy mice with an altered c-myc gene: role of the 3' untranslated region revisited.
Langa F; Lafon I; Vandormael-Pournin S; Vidaud M; Babinet C; Morello D
Oncogene; 2001 Jul; 20(32):4344-53. PubMed ID: 11466615
[TBL] [Abstract][Full Text] [Related]
17. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
18. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
19. c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death.
de Alborán IM; Baena E; Martinez-A C
Cell Death Differ; 2004 Jan; 11(1):61-8. PubMed ID: 12970677
[TBL] [Abstract][Full Text] [Related]
20. Macrophages and abnormal BCL-6 or c-MYC gene expression affect the resistance of peritoneal B cells to induction of hyporesponsiveness.
Liou LB; Wu MW; Chao WJ
Scand J Immunol; 2009 May; 69(5):447-56. PubMed ID: 19508376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
